{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:44:19Z","timestamp":1768448659815,"version":"3.49.0"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.6930","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T17:25:05Z","timestamp":1485883505000},"page":"353-356","source":"Crossref","is-referenced-by-count":8,"title":["The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet"],"prefix":"10.2169","volume":"56","author":[{"given":"Ryo","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Ohwada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Togasaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kawajiri","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shokichi","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shio","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"},{"name":"Division of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"},{"name":"Division of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Sakaida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Iseki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"},{"name":"Division of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Nakaseko","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Arvin AM. Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 6: 219-230, 2000.","DOI":"10.1016\/S1083-8791(00)70004-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 6: 44-49, 2000.","DOI":"10.1016\/S1083-8791(00)70051-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hackanson B, Zeiser R, Bley TA, et al. Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation. Clin Transplant 19: 566-570, 2005.","DOI":"10.1111\/j.1399-0012.2005.00382.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Thomson KJ, Hart DP, Banerjee L, et al. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 35: 1065-1069, 2005.","DOI":"10.1038\/sj.bmt.1704959"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kanda Y, Mineishi S, Saito T, et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 28: 689-692, 2001.","DOI":"10.1038\/sj.bmt.1703214"},{"key":"6","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","volume":"110","author":"V Erard","year":"2007","unstructured":"6. Erard V, Guthrie KA, Varley C, et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 110: 3071-3077, 2007.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Asano-Mori Y, Kanda Y, Oshima K, et al. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol 83: 472-476, 2008.","DOI":"10.1002\/ajh.21152"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kawamura K, Wada H, Yamasaki R, et al. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. Int J Infect Dis 19: 26-32, 2014.","DOI":"10.1016\/j.ijid.2013.09.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Suzuki J, Ashizawa M, Okuda S, et al. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 14: E7-E12, 2012.","DOI":"10.1111\/j.1399-3062.2012.00720.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Leveque N, Galambrun C, Najioullah F, et al. Two cases of varicella zoster virus meningitis found in pediatric patients after bone marrow transplantation despite valaciclovir prophylaxis and without skin lesions. J Med Virol 78: 514-516, 2006.","DOI":"10.1002\/jmv.20570"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fukuno K, Tomonari A, Takahashi S, et al. Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia. Int J Hematol 84: 79-82, 2006.","DOI":"10.1532\/IJH97.06044"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gregoire SM, van Pesch V, Goffette S, et al. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry 77: 938-942, 2006.","DOI":"10.1136\/jnnp.2006.090316"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57: 1114-1128, 2013.","DOI":"10.1093\/cid\/cit458"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kussmaul SC, Horn BN, Dvorak CC, et al. Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant 45: 1602-1606, 2010.","DOI":"10.1038\/bmt.2010.31"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sauerbrei A, Prager J, Hengst U, et al. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 20: 381-383, 1997.","DOI":"10.1038\/sj.bmt.1700909"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Issa NC, Marty FM, Leblebjian H, et al. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 20: 285-287, 2014.","DOI":"10.1016\/j.bbmt.2013.11.013"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15: 1143-1238, 2009.","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 44: 521-526, 2009.","DOI":"10.1038\/bmt.2009.263"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Flowers ME, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 117: 3214-3219, 2011.","DOI":"10.1182\/blood-2010-08-302109"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kanda J, Nakasone H, Atsuta Y, et al. Risk factors and organ involvement of chronic GVHD in Japan. Bone Marrow Transplant 49: 228-235, 2014.","DOI":"10.1038\/bmt.2013.151"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ihekwaba UK, Kudesia G, McKendrick MW. Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. Clin Infect Dis 47: 783-789, 2008.","DOI":"10.1086\/591129"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tauro S, Toh V, Osman H, et al. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient. Bone Marrow Transplant 26: 795-796, 2000.","DOI":"10.1038\/sj.bmt.1702599"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs 57: 187-206, 1999.","DOI":"10.2165\/00003495-199957020-00005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lee CC, Wu JC, Huang WC, et al. Herpes zoster cervical myelitis in a young adult. J Chin Med Assoc 73: 605-610, 2010.","DOI":"10.1016\/S1726-4901(10)70132-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Rosenfeld J, Taylor CL, Atlas SW. Myelitis following chickenpox: a case report. Neurology 43: 1834-1836, 1993.","DOI":"10.1212\/WNL.43.9.1834"},{"key":"26","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.44.10.1818","volume":"44","author":"DH Gilden","year":"1994","unstructured":"26. Gilden DH, Beinlich BR, Rubinstien EM, et al. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44: 1818-1823, 1994.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"27","unstructured":"27. Mehndiratta MM, Bansal J, Gupta M, et al. Herpes zoster cervical myelitis in an immunocompetent subject. Neurol India 48: 189-190, 2000."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/3\/56_56.6930\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:27:59Z","timestamp":1498368479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/3\/56_56.6930\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.6930","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}